Usage of and attitudes about green tea extract and Epigallocathechin-3-gallate (EGCG) as a therapy in individuals with Down syndrome.

CONCLUSIONS: These results demonstrate a need for communication between caregivers, medical providers, and scientists about potential benefits and risks for adverse effects of GTE, EGCG, and other nutritional supplements in individuals with DS. PMID: 31331567 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31331567?dopt=Abstract

Source: Complementary Therapies in Medicine - July 25, 2019 Category: Complementary Medicine Authors: Long R, Drawbaugh ML, Davis CM, Goodlett CR, Williams JR, Roper RJ Tags: Complement Ther Med Source Type: research